Artesunate shows potent anti-tumor activity in B-cell lymphoma

BACKGROUND: Although chemo-immunotherapy has led to an improved overall survival for most B-cell lymphoma types, relapsed and refractory disease remains a challenge. The malaria drug artesunate has previously been identified as a growth suppressor in some cancer types and was tested as a new treatme...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Hematol Oncol
Egile Nagusiak: Våtsveen, Thea Kristin, Myhre, Marit Renée, Steen, Chloé Beate, Wälchli, Sébastien, Lingjærde, Ole Christian, Bai, Baoyan, Dillard, Pierre, Theodossiou, Theodossis A., Holien, Toril, Sundan, Anders, Inderberg, Else Marit, Smeland, Erlend B., Myklebust, June Helen, Oksvold, Morten P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5819282/
https://ncbi.nlm.nih.gov/pubmed/29458389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0561-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak